Lisa Dalton
Plus aucun poste en cours
Fortune : 517 $ au 31/07/2023
Profil
Lisa Dalton served as the Head of Human Resources at Spark Therapeutics, Inc. from 2014 to 2019.
Prior to that, she was the Vice President of Human Resources at Shire Pharmaceuticals, Inc. She also served as an Independent Director at Nabriva Therapeutics Plc from 2021 to 2023.
Dalton received an undergraduate degree from The Pennsylvania State University and an MBA from Rutgers Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NABRIVA THERAPEUTICS PLC
0,01% | 31/01/2023 | 364 ( 0,01% ) | 517 $ | 31/07/2023 |
Anciens postes connus de Lisa Dalton
| Sociétés | Poste | Fin |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Directeur/Membre du Conseil | 30/07/2023 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Responsable des Ressources Humaines | - |
| SPARK THERAPEUTICS, INC. | Responsable des Ressources Humaines | - |
Formation de Lisa Dalton
| The Pennsylvania State University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
